Nexvet Announces Publication of Two Peer-Reviewed Journal Articles Profiling Frunevetmab (NV-02) and Presentation at the Veterinary Pain Short Course Conference

/in

DUBLIN, Ireland, July 20, 2016 (GLOBE NEWSWIRE) –Link here. Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic therapeutics company, today announced the recent publication of two peer-reviewed papers regarding frunevetmab in the Journal of Veterinary Internal Medicine (JVIM), as well as an upcoming presentation Nexvet’s Chief Scientific Officer Dr. David Gearing at the Veterinary Pain Short […]

Read more

SeaDragon appoints new Chief Executive

/in ,

NZX / MEDIA RELEASE 18 July 2016. Link here. SeaDragon appoints new Chief Executive Dr Nevin Amos to take the reins of the company in October 2016. SeaDragon Board thanks outgoing Interim Chief Executive Richard Alderton for leadership through the company’s transition to Omega-3 fish oil markets SeaDragon, New Zealand’s largest refiner and blender of […]

Read more

Saluda Medical featured in Nature Journal

/in ,

Biomedicine: Move over, morphine James Mitchell Crow Nature 535, S4–S6 (14 July 2016) Published online 13 July 2016   Link here.

Read more

Avita Medical announces Rights Issue raises $9 million

/in

Northridge, CA, Perth, Australia and London, United Kingdom – 11 July 2016 Avita Medical Ltd today announced a partially underwritten non-renounceable rights issue to raise up to approximately $11m (Rights Issue) to support the Company’s strategy to launch in the US and push forward with product commercialization. Link here.

Read more